1. Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study. (1st December 2022) Authors: Kawsar, Anusuya; Edwards, Charlotte; Patel, Pooja; Heywood, Richard M.; Gupta, Aakriti; Mann, Jasmine; Harland, Christopher; Heelan, Kara; Larkin, James; Lorigan, Paul; Harwood, Catherine A.; Matin, Rubeta N.; Fearfield, Louise Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study. (6th September 2022) Authors: Kawsar, Anusuya; Edwards, Charlotte; Patel, Pooja; Heywood, Richard M.; Gupta, Aakriti; Mann, Jasmine; Harland, Christopher; Heelan, Kara; Larkin, James; Lorigan, Paul; Harwood, Catherine A.; Matin, Rubeta N.; Fearfield, Louise Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗